Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1093/JMCB/MJY051 | ||||
| Año | 2019 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
The hair follicle is a biological oscillator that alternates growth, regression, and rest phases driven by the sequential activation of the proliferation/differentiation programs of resident stem cell populations. The activation of hair follicle stem cell niches and subsequent entry into the growing phase is mainly regulated by Wnt/-catenin signalling, while regression and resting phases are mainly regulated by Tgf-/Bmp/Smad activity. A major question still unresolved is the nature of the molecular switch that dictates the coordinated transition between both signalling pathways. Here we have focused on the role of Endoglin (Eng), a key co-receptor for members of the Tgf-/Bmp family of growth factors. Using an Eng haploinsufficient mouse model, we report that Eng is required to maintain a correct follicle cycling pattern and for an adequate stimulation of hair follicle stem cell niches. We further report that -catenin binds to the Eng promoter depending on Bmp signalling. Moreover, we show that -catenin interacts with Smad4 in a Bmp/Eng-dependent context and both proteins act synergistically to activate Eng promoter transcription. These observations point to the existence of a growth/rest switching mechanism in the hair follicle that is based on an Eng-dependent feedback cross-talk between Wnt/-catenin and Bmp/Smad signals.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | CALVO-SANCHEZ, MARIA, I | Mujer |
UNIV AUTONOMA MADRID - España
UFV - España Hosp Univ Ramon y Cajal - España Universidad Autónoma de Madrid - España Universidad Francisco de Vitoria - España Hospital Ramon y Cajal - España Hospital Universitario Ramón y Cajal - España Consejo Superior de Investigaciones Científicas - España |
| 2 | Fernandez-Martos, Sandra | Mujer |
Hosp Univ Ramon y Cajal - España
Hospital Ramon y Cajal - España Hospital Universitario Ramón y Cajal - España |
| 3 | Carrasco, Elisa | Mujer |
UNIV AUTONOMA MADRID - España
Universidad Autónoma de Madrid - España Consejo Superior de Investigaciones Científicas - España |
| 4 | Moreno-Bueno, Gema | Mujer |
UNIV AUTONOMA MADRID - España
Ctr Invest Biomed Red Canc CIBERONC - España Universidad Autónoma de Madrid - España Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) - España Centro de Investigación Biomédica en Red de Cáncer - España Consejo Superior de Investigaciones Científicas - España |
| 5 | Bernabeu, Carmelo | Hombre |
CSIC - España
Ctr Invest Biomed Red Enfermedades Raras CIBERER - España CSIC - Centro de Investigaciones Biologicas (CIB) - España Consejo Superior de Investigaciones Científicas - España |
| 6 | QUINTANILLA-AVILA, MIGUEL | Hombre |
UNIV AUTONOMA MADRID - España
Universidad Autónoma de Madrid - España Consejo Superior de Investigaciones Científicas - España |
| 7 | Espada, J. | Hombre |
UNIV AUTONOMA MADRID - España
Universidad Bernardo O'Higgins - Chile Hosp Univ Ramon y Cajal - España Universidad Autónoma de Madrid - España Consejo Superior de Investigaciones Científicas - España Hospital Universitario Ramón y Cajal - España |
| Fuente |
|---|
| Ministerio de Economía y Competitividad of Spain |
| Ministerio de Economía y Competitividad |
| European Regional Development Fund |
| Instituto de Salud Carlos III |
| European Regional Development Funds |
| Ministerio de EconomÃa y Competitividad |
| Comunidad de Madrid |
| UAM-FPI fellowship |
| Centro de InvestigaciOn Biomedica en Red de Enfermedades Raras (CIBERER) - European Regional Development Funds (FEDER) |
| Spanish MECD-FPU fellowship |
| Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares |
| MECD-FPU |
| UAM-FPI |
| Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares |
| Agradecimiento |
|---|
| This work was supported by grants from Ministerio de Economia y Competitividad of Spain (RTC -2014-2626-1 to J.E., SAF2013-46183-R to M.Q., and SAF2013-43421-R to C.B.), Comunidad de Madrid (52010/BMD-2359, SkinModel to J.E. and M.Q.), Instituto de Salud Carlos III (PI15/01458 to J.E.), and Centro de InvestigaciOn Biomedica en Red de Enfermedades Raras (CIBERER; ISCIII-CB06/07/0038 to C.B.) financed jointly by the European Regional Development Funds (FEDER). E.C. and M.I.C. were supported by Spanish MECD-FPU and UAM-FPI fellowships, respectively. |
| This work was supported by grants from Ministerio de Economía y Competitividad of Spain (RTC-2014-2626-1 to J.E., SAF2013-46183-R to M.Q., and SAF2013-43421-R to C.B.), Comunidad de Madrid (S2010/BMD-2359, SkinModel to J.E. and M.Q.), Instituto de Salud Carlos III (PI15/01458 to J.E.), and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER; ISCIII-CB06/07/0038 to C.B.) financed jointly by the European Regional Development Funds (FEDER). E.C. and M.I.C. were supported by Spanish MECD-FPU and UAM-FPI fellowships, respectively. |